April 6, 2007 (Mountain View and San Francisco, CA) – LAWFUEL – The Law Newswire – Law Jobs – Fenwick & West LLP represented Agilent Technologies, Inc. (NASDAQ: A) in its recently announced acquisition of Stratagene Corporation (NASDAQ: STGN). Stratagene, based in La Jolla, CA, is a developer, manufacturer and marketer of specialized life science research and diagnostic products. Under the terms of the agreement, Stratagene will operate as a division within Agilent’s Life Sciences Solutions Unit. The transaction is subject to certain closing conditions set forth in the merger agreement, including approval by Stratagene stockholders of the merger and regulatory review, and is expected to close in approximately 90 days.
More information about the transaction can be obtained from the Agilent Web site.
The Fenwick & West transaction team included corporate attorneys Doug Cogen and Lynda Twomey; executive compensation and employee benefits attorneys Scott Spector and Blake Martell; technology transactions attorneys Sergio Garcia, Rochelle Levy Karr, Spencer Glende and Christa Gaines; and antitrust attorney Mark Ostrau.
About Fenwick & West
Fenwick & West provides comprehensive legal services to technology and life sciences clients of national and international prominence. The firm is ranked by MergerMarket as one of the top 5 technology M&A practices in the U.S. and by Corporate Board Member as one of the top 5 corporate law firms in northern California for publicly traded companies.
